AU2910900A - Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments - Google Patents

Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments

Info

Publication number: AU2910900A
Authority: AU; Australia
Prior art keywords: benzazocin; methano; ols; hexahydro; medicaments
Prior art date: 1999-02-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU29109/00A

Inventor

Wolf-Dietrich Bechtel

Hans Briem

Adrian Carter

Matthias Grauert

Matthias Hoffmann

Rainer Palluk

Thomas Weiser

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharma GmbH and Co KG

Original Assignee

BOEHRINGER INGELHEIM PHARMA

Boehringer Ingelheim Pharma GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-23

Filing date

2000-02-12

Publication date

2000-09-14

2000-02-12 Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA

2000-09-14 Publication of AU2910900A publication Critical patent/AU2910900A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Other In-Based Heterocyclic Compounds (AREA)

AU29109/00A 1999-02-23 2000-02-12 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments Abandoned AU2910900A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19907874A DE19907874A1 (en)	1999-02-23	1999-02-23	New N-substituted hexahydro-2,6-methano-3-benzazocin-10-ol derivatives, as tension-dependent sodium channel blockers useful for treating e.g. arrhythmia, spasms, pain or neurodegenerative diseases
DE19907874		1999-02-23
PCT/EP2000/001160 WO2000050421A1 (en)	1999-02-23	2000-02-12	Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments

Publications (1)

Publication Number	Publication Date
AU2910900A true AU2910900A (en)	2000-09-14

Family

ID=7898638

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU29109/00A Abandoned AU2910900A (en)	1999-02-23	2000-02-12	Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments

Country Status (14)

Country	Link
EP (1)	EP1157020B1 (en)
JP (1)	JP2002537393A (en)
AR (1)	AR022718A1 (en)
AT (1)	ATE224890T1 (en)
AU (1)	AU2910900A (en)
CA (1)	CA2362697C (en)
CO (1)	CO5170499A1 (en)
DE (2)	DE19907874A1 (en)
DK (1)	DK1157020T3 (en)
ES (1)	ES2183786T3 (en)
PE (1)	PE20001487A1 (en)
PT (1)	PT1157020E (en)
UY (1)	UY26022A1 (en)
WO (1)	WO2000050421A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19957156A1 (en) *	1999-11-27	2001-05-31	Boehringer Ingelheim Pharma	New amino and fluoro substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine derivatives useful in treatment of e.g. arrythmias, spasms, ischaemia, pain and neurodegenerative disorders
US6355652B1 (en)	1999-11-27	2002-03-12	Boehringer Ingelheim Pharma Kg	Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
US20030045449A1 (en) *	2001-08-15	2003-03-06	Pfizer, Inc.	Pharmaceutical combinations for the treatment of neurodegenerative diseases
US6683089B2 (en)	2002-02-02	2004-01-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols
DE10204276A1 (en) *	2002-02-02	2003-08-07	Boehringer Ingelheim Pharma	N-Allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceuticals
CL2008003407A1 (en) *	2007-11-16	2010-01-11	Boehringer Ingelheim Int	Substituted heterobicyclo aryl- and heteroarylcarbonyl derivative compounds; pharmaceutical composition; preparation procedure; and its use in the treatment and / or prevention of metabolic disorders, mediated by the inhibition of the enzyme hsd-1.
JP7289119B2 (en) *	2019-02-15	2023-06-09	国立大学法人千葉大学	Method for Synthesizing Optically Active Substituted Tetrahydrofuran Derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1575009A (en) *	1976-06-21	1980-09-17	Acf Chemiefarma Nv	6,7-benzomorphan derivatives
AU524600B2 (en) *	1976-09-22	1982-09-23	Sterling Drug Inc.	2,6-methano-3-benzazocines
JPS5513253A (en) *	1978-07-15	1980-01-30	Res Inst For Prod Dev	Cis-3-aralkyl substituted-8-benzoylthio-6,11-dimethyl-2,6- methano-1,2,3,4,5,6-hexahydro-3-benzazocine or its acid addition salt
DE3839659A1 (en) *	1988-11-24	1990-05-31	Boehringer Ingelheim Kg	USE OF BENZOMORPHANES FOR CYTOPROTECTION

1999
- 1999-02-23 DE DE19907874A patent/DE19907874A1/en not_active Withdrawn
2000
- 2000-02-12 DK DK00907557T patent/DK1157020T3/en active
- 2000-02-12 AT AT00907557T patent/ATE224890T1/en not_active IP Right Cessation
- 2000-02-12 DE DE50000560T patent/DE50000560D1/en not_active Expired - Fee Related
- 2000-02-12 WO PCT/EP2000/001160 patent/WO2000050421A1/en active IP Right Grant
- 2000-02-12 CA CA002362697A patent/CA2362697C/en not_active Expired - Fee Related
- 2000-02-12 AU AU29109/00A patent/AU2910900A/en not_active Abandoned
- 2000-02-12 ES ES00907557T patent/ES2183786T3/en not_active Expired - Lifetime
- 2000-02-12 JP JP2000601001A patent/JP2002537393A/en active Pending
- 2000-02-12 EP EP00907557A patent/EP1157020B1/en not_active Expired - Lifetime
- 2000-02-12 PT PT00907557T patent/PT1157020E/en unknown
- 2000-02-21 PE PE2000000132A patent/PE20001487A1/en not_active Application Discontinuation
- 2000-02-21 UY UY26022A patent/UY26022A1/en unknown
- 2000-02-22 CO CO00012191A patent/CO5170499A1/en not_active Application Discontinuation
- 2000-02-23 AR ARP000100754A patent/AR022718A1/en active Pending

Also Published As

Publication number	Publication date
CA2362697A1 (en)	2000-08-31
DE19907874A1 (en)	2000-08-24
UY26022A1 (en)	2000-09-29
ES2183786T3 (en)	2003-04-01
CO5170499A1 (en)	2002-06-27
EP1157020B1 (en)	2002-09-25
DE50000560D1 (en)	2002-10-31
DK1157020T3 (en)	2003-01-27
PT1157020E (en)	2003-01-31
PE20001487A1 (en)	2001-01-18
ATE224890T1 (en)	2002-10-15
EP1157020A1 (en)	2001-11-28
AR022718A1 (en)	2002-09-04
WO2000050421A1 (en)	2000-08-31
JP2002537393A (en)	2002-11-05
CA2362697C (en)	2008-04-22

Similar Documents

Publication	Publication Date	Title
AU6198700A (en)	2001-02-05	Process for producing phenyl-alkanes compositions produced therefrom, and uses thereof
HU9802224D0 (en)	1998-11-30	Pyrazol derivatives, process for producing them and their use as medicament
AU4048299A (en)	2000-01-05	Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
HUP0105478A2 (en)	2002-06-29	16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
HK1028769A1 (en)	2001-03-02	2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
HUP0000748A3 (en)	2003-12-29	4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
AU2856499A (en)	2000-10-16	Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
HUP9900120A3 (en)	2001-02-28	Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP0004747A3 (en)	2002-12-28	4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline derivatives and process for their preparation
AU7961200A (en)	2001-05-14	Urea derivative, process for producing the same, and medicine containing the urea derivative
AU3156600A (en)	2000-09-04	Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
IL134572A (en)	2005-05-17	Substituted 1,2,3,4,5,6-hexahydro-2, 6-methano-3-benzazocin - 10 -ols, methods for their production and use thereof as medicaments
AU4134297A (en)	1998-03-26	2,4-disubstituted pyrimidine derivatives, process for producing the same, and medicinal compositions containing the same
AU769160C (en)	2006-02-23	Morphine sulphate microgranules, method for preparing same and compositions containing same
HUP0103316A3 (en)	2002-06-28	2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use
HUP0201785A3 (en)	2003-02-28	Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them
HUP9701660A3 (en)	1998-08-28	10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, and pharmaceutical compositions containing them
AU2910900A (en)	2000-09-14	Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments
AU3825700A (en)	2000-11-14	Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
AU2851899A (en)	1999-09-27	Method for producing 2,2'-dihydroxybiphenyls
AU2547399A (en)	1999-09-15	Pyridone derivatives and process for producing the same
HUP9900263A3 (en)	2000-04-28	11-acetyl-12,13-dioxabicyclo[8.2.1.]tridecenon derivatives, process for producing them and pharmaceutical compositions containing them
AU4107100A (en)	2000-11-02	Method of producing composites, composites and the use of such composites
AU7773700A (en)	2001-04-10	Method for the production or preparation of 2,6-dichlorotoluol
AU4845196A (en)	1997-09-22	2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient

Legal Events

Date	Code	Title	Description
2002-01-17	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase